DSM-Firmenich said in its July 30 financial report that its previously announced restructuring could lead to a reduction of approximately 1,000 positions over the next 18-24 months.
“We are delivering on the action plan outlined at our 2026 Capital Markets Day, focused on accelerating top-line growth, margin expansion and maintaining disciplined cash and capital management,” said CEO Dimitri de Vreeze. “These initiatives will drive a further sequential improvement to deliver an around 20% adjusted EBITDA margin in 2026. We are also executing our cost savings and restructuring program, to provide a strong foundation to achieve a further step-up in margin in 2027.”
